Glucose control and outcome in patients with stable diabetes and previous coronary, cerebrovascular or peripheral artery disease. Findings from the FRENA Registry

Diabetic Medicine

Volumn 28, Issue 1, 2011, Pages 73-80

  Camafort, M ^a   Alvarez Rodriguez L R ^b   Munoz Torrero J F S ^c   Sahuquillo, J C ^d   Lopez Jimenez L ^e   Coll, R ^f   Monreal, M ^f  

^a Hospital Comarcal Mora d'Ebre   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c HOSPITAL SAN PEDRO DE ALCÁNTARA   (Spain)

^d Hospital Municipal de Badalona   (Spain)

^e HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^f HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

Author keywords

Arterial disease; Diabetes; Glucose control; Ischaemic events; Secondary prevention

Indexed keywords

HEMOGLOBIN A1C;

AGED; ARTICLE; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CREATININE CLEARANCE; DIABETES MELLITUS; DIABETIC PATIENT; ELECTROCARDIOGRAM; FEMALE; FOLLOW UP; GLYCEMIC CONTROL; HEART INFARCTION; HUMAN; LIMB ISCHEMIA; MAJOR CLINICAL STUDY; MALE; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; OUTPATIENT; STROKE;

AGED; BODY MASS INDEX; CEREBROVASCULAR DISORDERS; CORONARY ARTERY DISEASE; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; PERIPHERAL VASCULAR DISEASES; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RISK FACTORS; SPAIN; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 78650249241     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2010.03153.x     Document Type: Article

References (23)

1. Moss SE, Klein R, Klein BE, Meuer SM. The association of glycemia and cause-specific mortality in a diabetic population. Arch Intern Med 1994; 154: 2473-2479.
2. Khaw KT, Wareham N, Luben R, Bingham S, Oakes S, Welch A et al. Glycated haemoglobin, diabetes, and mortality in men in Norfolk Cohort of European Prospective Investigation of cancer and nutrition (EPIC-Norfolk). Br Med J 2001; 322: 15-18.
3. Selvin E, Coresh J, Golden SH, Brancati FL, Folsom AR, Steffes MW. Glycemic control and coronary heart disease risk in persons with and without diabetes. The Atherosclerosis Risk in Communities Study. Arch Intern Med 2005; 165: 1910-16.
4. Deedwania P, Kosiborod M, Barrett E, Ceriello A, Isley W, Mazzone T et al. American Heart Association Diabetes Committee of the Council of Nutrition, Physical Activity, and Metabolism. Hyperglycemia and acute coronary syndrome: a scientific statement from the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 2008; 117: 1610-1619.
5. Ryden L, Standl E, Bartnik M, Van den Berghe G, Betteridge J, de Boer MJ et al. Guidelines on diabetes, pre-diabetes and cardiovascular diseases: Executive summary. The Task Force on diabetes and cardiovascular diseases of the European Society of Cardiology (ESC) and the European Association for the study of diabetes (EASD). Eur Heart J 2007; 28: 88-136.
6. Antman EM, Armstrong PW, Bates ER, Bates ER, Green LA, Halasyamani LK et al. 2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the Canadian Cardiovascular Society endorsed by the American Academy of Family Physicians: 2007 writing group to review new evidence and update the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction, writing on behalf of the 2004 writing committee. Circulation 2008; 117: 296-329.
7. Adams RJ, Albers G, Alberts MJ, Benavente O, Furie K, Goldstein LB et al., American Heart Association, American Stroke Association Update to the AHA/ASA recommendations for the prevention of stroke in patients with stroke and transient ischemic attack. Stroke 2008; 39: 1647-1652.
8. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FGR, on behalf of the TASC II Working Group. Inter-Society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg 2007; 33: S1-S75.
9. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care 2010; 33: S12-S61.
10. Stratton JM, Adler AI, Neil HA, Yudkin JS, Matthews DR, Cull CA. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS-35): Prospective observational study. Br Med J 2000; 321: 405-412.
11. Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008; 358: 2545-2559.
12. Patel A, MacMahon S, Chalmers J, Neal B, Billot L, Woodward M et al., ADVANCE Collaborative Group Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008; 358: 2560-2572.
13. Duckworth W, Abraira C, Moritz T, Reda D, Emanuele N, Reaven PD et al.; VADT Investigators Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 2009; 360: 129-139.
14. Suriñach JM, Alvarez LR, Coll R, Carmona JA, Sanclemente C, Aguilar E et al., and the FRENA Investigators Differences in cardiovascular mortality in smokers, past smokers and non-smokers. Findings from the FRENA registry. Eur J Intern Med 2009; 20: 522-526.
15. Barba R, Bisbe J, Pedrajas JN, Toril J, Monte R, Muñoz-Torrero JF et al., and the FRENA Investigators Body mass index and outcome in patients with coronary, cerebrovascular or peripheral artery disease: Findings from the FRENA Registry. Eur J Cardiovasc Prev Rehabil 2009; 16: 457-463.
16. Gadelha T, Bisbe J, Toril J, Alcalá-Pedrajas JN, Monreal M and the FRENA investigators. Major bleeding events in stable outpatients with coronary, cerebrovascular or periheral artery disease. Findings from the FRENA Registry. J Thromb Haemost 2009; 7: 1414-1416.
17. Dormandy JA, Rutherford B. Management of peripheral arterial disease (PAD) TASC Working Group. Trans Atlantic Inter-Society Consensus (TASC). J Vasc Surg 2000; 31: S1-S96.
18. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31-41.
19. Martin DO, Austin H. Exact estimates for a rate ratio. Epidemiology 1996; 7: 29-33.
20. Skyler JS, Bergenstal R, Bonow RO, Buse J, Deedwania P, Gale EA et al. Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE and VA diabetes trials. A position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association. Circulation 2009; 119: 351-357.
21. Ray KK, Seshasai SRK, Wijesuriya S, Sivakumaran R, Nethercott S, Preiss D et al. Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials. Lancet 2009; 373: 1765-1772.
22. Kelly TN, Bazzano LA, Fonseca VA, Thethi TK, Reynolds K, He J. Systematic review: glucose control and cardiovascular disease in type 2 diabetes. Ann Intern Med 2009; 151: 394-403.
23. Turnbull FM, Abraira C, Anderson RJ, Byington RP, Chalmers JP, Duckworth WC et al. Intensive glucose control and macrovascular outcomes in type 2 diabetes. Diabetologia 2009; 52: 2288-2298.